Medicines Classification Committee 60th agenda

By

22/3/2018. In this submission we provided comments on seven agenda items. Trimethoprim – usage and resistance following reclassification. Clotrimazole and hydrocortisone - proposed reclassification from restricted medicine to pharmacy-only medicine (Canesten Plus, Bayer New Zealand Limited. Loratadine – proposed reclassification from pharmacy-only medicine to general sale medicine (Claratyne, Bayer New Zealand Limited). Influenza vaccine – proposed amendment to prescription except when classification (Pharmaceutical Society of New Zealand). Melatonin – proposed reclassification from prescription medicine (Individual submission). Modified-release paracetamol – proposed reclassification from pharmacy-only medicine to restricted medicine. Sedating antihistamine – proposed amendment to restricted medicine classification.

22/3/2018. In this submission we provided comments on seven agenda items. Trimethoprim – usage and resistance following reclassification. Clotrimazole and hydrocortisone - proposed reclassification from restricted medicine to pharmacy-only medicine (Canesten Plus, Bayer New Zealand Limited. Loratadine – proposed reclassification from pharmacy-only medicine to general sale medicine (Claratyne, Bayer New Zealand Limited). Influenza vaccine – proposed amendment to prescription except when classification (Pharmaceutical Society of New Zealand). Melatonin – proposed reclassification from prescription medicine (Individual submission). Modified-release paracetamol – proposed reclassification from pharmacy-only medicine to restricted medicine. Sedating antihistamine – proposed amendment to restricted medicine classification.

If you've forgotten your password enter your email address in the field above and click “Forgot Password” to have it emailed to you. Forgot Password